{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:41Z","timestamp":1759403441127,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.023","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T08:11:22Z","timestamp":1603527082000},"page":"7834-7841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing"],"prefix":"10.1016","volume":"38","author":[{"given":"Marta","family":"Valente Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-2684","authenticated-orcid":false,"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-5242","authenticated-orcid":false,"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Karin","family":"Nordgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vipond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Plested","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2020.10.023_b0005","article-title":"Adverse Events Following Immunization: Will It Happen Again?","volume":"140","author":"O'Leary","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.10.023_b0010","unstructured":"European Centre for Disease Preventation and Control. Let\u2019s talk about hesitancy. Stockholm: ECDC; 2016."},{"key":"10.1016\/j.vaccine.2020.10.023_b0015","article-title":"State of vaccine confidence in the EU 2018","author":"Larson","year":"2018","journal-title":"European Comission"},{"issue":"10061","key":"10.1016\/j.vaccine.2020.10.023_b0020","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.10.023_b0025","unstructured":"European Centre for Disease Preventation and Control. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU\/EEA. Stockholm: ECDC; 2017"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.023_b0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.023_b0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jama.2012.85","article-title":"Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial","volume":"307","author":"Gossger","year":"2012","journal-title":"JAMA"},{"issue":"9869","key":"10.1016\/j.vaccine.2020.10.023_b0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.023_b0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jinf.2015.09.035","article-title":"The introduction of the meningococcal B (MenB) vaccine (Bexsero\u00ae) into the national infant immunisation programme: New challenges for public health","volume":"71","author":"Ladhani","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.10.023_b0050","article-title":"An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study","volume":"312941","author":"Nainani","year":"2017","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.023_b0055","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/archdischild-2017-313079","article-title":"Risk of hospitalisation with fever following MenB vaccination: self-controlled case series analysis","volume":"102","author":"Murdoch","year":"2017","journal-title":"Arch Dis Child"},{"issue":"11","key":"10.1016\/j.vaccine.2020.10.023_b0060","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol J"},{"issue":"2","key":"10.1016\/j.vaccine.2020.10.023_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"Goldblatt","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2020.10.023_b0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.physbeh.2006.04.026","article-title":"Evaluation of wireless determination of skin temperature using iButtons","volume":"88","author":"van Marken Lichtenbelt","year":"2006","journal-title":"Physiol Behav"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2020.10.023_b0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Michael Marcy","year":"2004","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2020.10.023_b0080","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1016\/j.vaccine.2018.06.038","article-title":"Development and validation of a monocyte activation test for the control\/safety testing of an OMV-based meningococcal B vaccine","volume":"37","author":"Vipond","year":"2019","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2020.10.023_b0085","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1016\/j.vaccine.2018.10.082","article-title":"Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations","volume":"37","author":"Valentini","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.023_b0090","unstructured":"Public Health England Meningococcal: the green book, chapter 22 2013, last update 20 September 2016."},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.023_b0095","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.023_b0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1088\/0967-3334\/31\/1\/007","article-title":"The validity of wireless iButtons\u00ae and thermistors for human skin temperature measurement","volume":"31","author":"Smith","year":"2010","journal-title":"Physiol Meas"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.023_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2010.12.011","article-title":"The validity, reliability, and utility of the iButton\u00ae for measurement of body temperature circadian rhythms in sleep\/wake research","volume":"14","author":"Hasselberg","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.vaccine.2020.10.023_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-3223(97)83214-3","article-title":"Core body temperature is normal in Chronic Fatigue Syndrome","volume":"43","author":"Hamilos","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.023_b0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jat.2720","article-title":"Nonclinical vaccine safety evaluation: advantages of continuous temperature monitoring using abdominally implanted data loggers","volume":"33","author":"Kaaijk","year":"2013","journal-title":"J Appl Toxicol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.023_b0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1109\/JBHI.2014.2368774","article-title":"Skin Temperature Prediction in Lower Limb Prostheses","volume":"20","author":"Mathur","year":"2016","journal-title":"IEEE J Biomed Health Inform"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.023_b0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/07420528.2011.565895","article-title":"Assessment of circadian rhythms of both skin temperature and motor activity in infants during the first 6 months of life","volume":"28","author":"Zornoza-Moreno","year":"2011","journal-title":"Chronobiol Int"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.10.023_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365513.2018.1519722","article-title":"Evaluation of commercial, wireless dermal thermometers for surrogate measurements of core temperature","volume":"79","author":"Zsuzsanna Balla","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2020.10.023_b0135","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc12894","article-title":"Body temperature patterns as a predictor of hospital-acquired sepsis in afebrile adult intensive care unit patients: a case-control study","volume":"17","author":"Drewry","year":"2013","journal-title":"Crit Care"},{"issue":"33","key":"10.1016\/j.vaccine.2020.10.023_b0140","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1016\/j.vaccine.2016.05.054","article-title":"A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11\u201312 months","volume":"34","author":"Silfverdal","year":"2016","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2020.10.023_b0145","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.vaccine.2017.05.023","article-title":"Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial","volume":"35","author":"Martinon-Torres","year":"2017","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2020.10.023_b0150","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1016\/j.vaccine.2012.05.064","volume":"30","author":"Berner","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.023_b0155","doi-asserted-by":"crossref","unstructured":"Canadian Paediatric Society Statement. Temperature measurement in paediatrics - CP 2000-01. Paediatr Child Health. 2000;5(5):273\u20136.","DOI":"10.1093\/pch\/5.5.273"},{"issue":"6","key":"10.1016\/j.vaccine.2020.10.023_b0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/tropej\/fmq120","article-title":"A comparison of different methods of temperature measurements in sick newborns","volume":"57","author":"Uslu","year":"2011","journal-title":"J Trop Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:35Z","timestamp":1759402175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313165"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}